{"date":"2026-06-25","count":59,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6659-2026-06-25-2025-1g41lqr","company_id":"6659","company":"天明製藥","market":"興櫃","industry":"生技醫療","date":"2026-06-25","time":"20:25:45","subject":"公告本公司薪資報酬委員會委員任期屆滿","clause":"第6款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：天明製藥（6659），2026-06-25 20:25，「公告本公司薪資報酬委員會委員任期屆滿」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6659-2026-06-25-2024-n3db9h","company_id":"6659","company":"天明製藥","market":"興櫃","industry":"生技醫療","date":"2026-06-25","time":"20:24:58","subject":"公告本公司審計委員會新任委員名單","clause":"第6款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：天明製藥（6659），2026-06-25 20:24，「公告本公司審計委員會新任委員名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6659-2026-06-25-2024-1hepuoh","company_id":"6659","company":"天明製藥","market":"興櫃","industry":"生技醫療","date":"2026-06-25","time":"20:24:04","subject":"公告本公司115年股東常會解除董事競業禁止之限制。","clause":"第22款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：天明製藥（6659），2026-06-25 20:24，「公告本公司115年股東常會解除董事競業禁止之限制。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6659-2026-06-25-2018-wan9s5","company_id":"6659","company":"天明製藥","market":"興櫃","industry":"生技醫療","date":"2026-06-25","time":"20:18:57","subject":"公告本公司115年股東常會全面改選董事(含獨立董事四席)。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：天明製藥（6659），2026-06-25 20:18，「公告本公司115年股東常會全面改選董事(含獨立董事四席)。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6659-2026-06-25-2015-1jb8ii5","company_id":"6659","company":"天明製藥","market":"興櫃","industry":"生技醫療","date":"2026-06-25","time":"20:15:19","subject":"公告本公司115年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：天明製藥（6659），2026-06-25 20:15，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2026-06-25-1948-10lqs79","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2026-06-25","time":"19:48:27","subject":"依公開發行公司資金貸與及背書保證處理準則第二十二條第三款公告","clause":"第23款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2026-06-25 19:48，「依公開發行公司資金貸與及背書保證處理準則第二十二條第三款公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2026-06-25-1942-zkkjkj","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2026-06-25","time":"19:42:49","subject":"公告本公司董事會決議委任永續發展委員會委員","clause":"第6款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2026-06-25 19:42，「公告本公司董事會決議委任永續發展委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2026-06-25-1942-1eaiuug","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2026-06-25","time":"19:42:25","subject":"公告本公司董事會決議委任薪資報酬委員會委員","clause":"第6款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2026-06-25 19:42，「公告本公司董事會決議委任薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2026-06-25-1942-1siwt45","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2026-06-25","time":"19:42:08","subject":"公告本公司普通股現金股利除息基準日","clause":"第14款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2026-06-25 19:42，「公告本公司普通股現金股利除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2026-06-25-1941-isqttc","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2026-06-25","time":"19:41:31","subject":"公告本公司董事會重要決議事項","clause":"第53款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2026-06-25 19:41，「公告本公司董事會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4747-2026-06-25-1910-whyalj","company_id":"4747","company":"強生*","market":"上櫃","industry":"生技醫療","date":"2026-06-25","time":"19:10:13","subject":"公告本公司每股面額變更為新台幣5元辦理資本變更登記完成","clause":"第36款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：強生*（4747），2026-06-25 19:10，「公告本公司每股面額變更為新台幣5元辦理資本變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6847-2026-06-25-1835-1uhskx3","company_id":"6847","company":"普瑞博","market":"興櫃","industry":"生技醫療","date":"2026-06-25","time":"18:35:47","subject":"公告本公司董事會決議辦理現金增資發行新股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普瑞博（6847），2026-06-25 18:35，「公告本公司董事會決議辦理現金增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6461-2026-06-25-1833-5ewst2","company_id":"6461","company":"益得","market":"上櫃","industry":"生技醫療","date":"2026-06-25","time":"18:33:08","subject":"公告本公司訂定減資基準日","clause":"第11款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：益得（6461），2026-06-25 18:33，「公告本公司訂定減資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3218-2026-06-25-1812-6rqyk5","company_id":"3218","company":"大學光","market":"上櫃","industry":"生技醫療","date":"2026-06-25","time":"18:12:59","subject":"公告本公司取得有價證券","clause":"第20款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：大學光（3218），2026-06-25 18:12，「公告本公司取得有價證券」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2026-06-25-1805-2fody5","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2026-06-25","time":"18:05:32","subject":"代重要子公司優良生技醫藥股份有限公司公告115年股東會重要決議事項","clause":"第18款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2026-06-25 18:05，「代重要子公司優良生技醫藥股份有限公司公告115年股東會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4121-2026-06-25-1801-1bb0fre","company_id":"4121","company":"優盛","market":"上櫃","industry":"生技醫療","date":"2026-06-25","time":"18:01:20","subject":"公告董事會決議擬延長處份部份子公司佑全藥品(股)公司股權案之授權期間屆滿。(補充115/03/27取處公告)","clause":"第20款","fact_date":"2026-03-27","cite_as":"公開資訊觀測站重大訊息：優盛（4121），2026-06-25 18:01，「公告董事會決議擬延長處份部份子公司佑全藥品(股)公司股權案之授權期間屆滿。(補充115/03/27取處公告)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6815-2026-06-25-1800-1hdkn23","company_id":"6815","company":"晶鑽生醫","market":"興櫃","industry":"生技醫療","date":"2026-06-25","time":"18:00:15","subject":"公告本公司董事會決議委任第三屆薪資報酬委員會委員","clause":"第6款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：晶鑽生醫（6815），2026-06-25 18:00，「公告本公司董事會決議委任第三屆薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6815-2026-06-25-1759-1r2d1uw","company_id":"6815","company":"晶鑽生醫","market":"興櫃","industry":"生技醫療","date":"2026-06-25","time":"17:59:57","subject":"公告本公司第三屆審計委員會委員","clause":"第6款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：晶鑽生醫（6815），2026-06-25 17:59，「公告本公司第三屆審計委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6815-2026-06-25-1758-1n1y3kt","company_id":"6815","company":"晶鑽生醫","market":"興櫃","industry":"生技醫療","date":"2026-06-25","time":"17:58:05","subject":"公告本公司董事長續任","clause":"第6款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：晶鑽生醫（6815），2026-06-25 17:58，「公告本公司董事長續任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6847-2026-06-25-1755-12gv02m","company_id":"6847","company":"普瑞博","market":"興櫃","industry":"生技醫療","date":"2026-06-25","time":"17:55:40","subject":"公告本公司董事會通過會計主管、財務主管、公司治理主管任命案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普瑞博（6847），2026-06-25 17:55，「公告本公司董事會通過會計主管、財務主管、公司治理主管任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6815-2026-06-25-1751-cr5gmb","company_id":"6815","company":"晶鑽生醫","market":"興櫃","industry":"生技醫療","date":"2026-06-25","time":"17:51:35","subject":"公告本公司115年股東常會決議解除董事競業禁止之限制","clause":"第22款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：晶鑽生醫（6815），2026-06-25 17:51，「公告本公司115年股東常會決議解除董事競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7725-2026-06-25-1746-jflio5","company_id":"7725","company":"列特博","market":"興櫃","industry":"生技醫療","date":"2026-06-25","time":"17:46:17","subject":"公告本公司115年股東會重要決議事項","clause":"第15款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：列特博（7725），2026-06-25 17:46，「公告本公司115年股東會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6815-2026-06-25-1731-1rayw5g","company_id":"6815","company":"晶鑽生醫","market":"興櫃","industry":"生技醫療","date":"2026-06-25","time":"17:31:51","subject":"公告本公司115年股東常會全面改選董事(含獨立董事)當選名單","clause":"第6款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：晶鑽生醫（6815），2026-06-25 17:31，「公告本公司115年股東常會全面改選董事(含獨立董事)當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6815-2026-06-25-1731-1jb8ii5","company_id":"6815","company":"晶鑽生醫","market":"興櫃","industry":"生技醫療","date":"2026-06-25","time":"17:31:32","subject":"公告本公司115年股東常會重要決議事項","clause":"第15款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：晶鑽生醫（6815），2026-06-25 17:31，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6986-2026-06-25-1729-1igyjof","company_id":"6986","company":"和迅","market":"上櫃","industry":"生技醫療","date":"2026-06-25","time":"17:29:00","subject":"公告本公司洽定上櫃買賣開始日並自同日起終止興櫃買賣","clause":"第28款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：和迅（6986），2026-06-25 17:29，「公告本公司洽定上櫃買賣開始日並自同日起終止興櫃買賣」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6850-2026-06-25-1711-1jb8ii5","company_id":"6850","company":"光鼎生技","market":"興櫃","industry":"生技醫療","date":"2026-06-25","time":"17:11:17","subject":"公告本公司115年股東常會重要決議事項","clause":"第15款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：光鼎生技（6850），2026-06-25 17:11，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6891-2026-06-25-1707-1bpz040","company_id":"6891","company":"樂迦再生","market":"興櫃","industry":"生技醫療","date":"2026-06-25","time":"17:07:26","subject":"公告本公司115年股東常會決議解除董事競業行為之限制","clause":"第22款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：樂迦再生（6891），2026-06-25 17:07，「公告本公司115年股東常會決議解除董事競業行為之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6891-2026-06-25-1706-1jb8ii5","company_id":"6891","company":"樂迦再生","market":"興櫃","industry":"生技醫療","date":"2026-06-25","time":"17:06:23","subject":"公告本公司115年股東常會重要決議事項","clause":"第15款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：樂迦再生（6891），2026-06-25 17:06，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2026-06-25-1706-1hu40k1","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2026-06-25","time":"17:06:06","subject":"公告本公司薪酬委員會委員異動","clause":"第6款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2026-06-25 17:06，「公告本公司薪酬委員會委員異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4104-2026-06-25-1658-rwgt0m","company_id":"4104","company":"佳醫","market":"上市","industry":"生技醫療","date":"2026-06-25","time":"16:58:03","subject":"公告本公司一一五年股東常會通過解除部分董事競業禁止之限制","clause":"第21款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：佳醫（4104），2026-06-25 16:58，「公告本公司一一五年股東常會通過解除部分董事競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4104-2026-06-25-1655-1dfxd4q","company_id":"4104","company":"佳醫","market":"上市","industry":"生技醫療","date":"2026-06-25","time":"16:55:33","subject":"公告本公司一一五年股東常會重要決議事項","clause":"第18款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：佳醫（4104），2026-06-25 16:55，「公告本公司一一五年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2026-06-25-1653-8dqhff","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2026-06-25","time":"16:53:48","subject":"本公司董事會決議發行限制員工權利新股之增資基準日","clause":"第51款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2026-06-25 16:53，「本公司董事會決議發行限制員工權利新股之增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2026-06-25-1653-w7a1p1","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2026-06-25","time":"16:53:13","subject":"公告本公司追認修訂115年度限制員工權利新股發行辦法","clause":"第11款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2026-06-25 16:53，「公告本公司追認修訂115年度限制員工權利新股發行辦法」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4117-2026-06-25-1653-1uznfe","company_id":"4117","company":"普生","market":"興櫃","industry":"生技醫療","date":"2026-06-25","time":"16:53:06","subject":"公告本公司115年05月份自結合併財務報告之負債比率、流動比率及速動比率","clause":"第44款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：普生（4117），2026-06-25 16:53，「公告本公司115年05月份自結合併財務報告之負債比率、流動比率及速動比率」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7881-2026-06-25-1631-jflio5","company_id":"7881","company":"科明","market":"興櫃","industry":"生技醫療","date":"2026-06-25","time":"16:31:46","subject":"公告本公司115年股東會重要決議事項","clause":"第15款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：科明（7881），2026-06-25 16:31，「公告本公司115年股東會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6704-2026-06-25-1612-zk0qd9","company_id":"6704","company":"國璽幹細胞","market":"興櫃","industry":"生技醫療","date":"2026-06-25","time":"16:12:55","subject":"公告本公司115年股東常會重要決議事項。","clause":"第15款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：國璽幹細胞（6704），2026-06-25 16:12，「公告本公司115年股東常會重要決議事項。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2026-06-25-1608-ss0ao7","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2026-06-25","time":"16:08:24","subject":"公告本公司股東常會通過解除董事及其代表人競業禁止之限制","clause":"第21款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：益安（6499），2026-06-25 16:08，「公告本公司股東常會通過解除董事及其代表人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6543-2026-06-25-1607-lfcvz2","company_id":"6543","company":"普惠醫工","market":"興櫃","industry":"生技醫療","date":"2026-06-25","time":"16:07:07","subject":"公告本公司發言人、財務主管、會計主管及公司治理主管異動","clause":"第11款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：普惠醫工（6543），2026-06-25 16:07，「公告本公司發言人、財務主管、會計主管及公司治理主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7762-2026-06-25-1602-lxno83","company_id":"7762","company":"吉晟生","market":"興櫃","industry":"生技醫療","date":"2026-06-25","time":"16:02:08","subject":"公告本公司董事會決議115年除權息基準日","clause":"第31款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：吉晟生（7762），2026-06-25 16:02，「公告本公司董事會決議115年除權息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7762-2026-06-25-1600-3il1nf","company_id":"7762","company":"吉晟生","market":"興櫃","industry":"生技醫療","date":"2026-06-25","time":"16:00:35","subject":"公告本公司115年度股東常會重要決議事項","clause":"第15款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：吉晟生（7762），2026-06-25 16:00，「公告本公司115年度股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2026-06-25-1559-ijk1kj","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2026-06-25","time":"15:59:58","subject":"本公司與B dot Medical Inc.簽署合作意向書","clause":"第10款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2026-06-25 15:59，「本公司與B dot Medical Inc.簽署合作意向書」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2026-06-25-1559-1jb8ii5","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2026-06-25","time":"15:59:42","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：益安（6499），2026-06-25 15:59，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3184-2026-06-25-1550-1byd9cs","company_id":"3184","company":"微邦","market":"興櫃","industry":"生技醫療","date":"2026-06-25","time":"15:50:28","subject":"本公司研發主管職務異動","clause":"第11款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：微邦（3184），2026-06-25 15:50，「本公司研發主管職務異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3184-2026-06-25-1549-agchak","company_id":"3184","company":"微邦","market":"興櫃","industry":"生技醫療","date":"2026-06-25","time":"15:49:52","subject":"公告本公司114年度現金股利配發基準日","clause":"第31款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：微邦（3184），2026-06-25 15:49，「公告本公司114年度現金股利配發基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3184-2026-06-25-1549-lewzru","company_id":"3184","company":"微邦","market":"興櫃","industry":"生技醫療","date":"2026-06-25","time":"15:49:33","subject":"公告本公司2026年股東常會重要決議事項","clause":"第15款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：微邦（3184），2026-06-25 15:49，「公告本公司2026年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7607-2026-06-25-1535-1jb8ii5","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2026-06-25","time":"15:35:30","subject":"公告本公司115年股東常會重要決議事項","clause":"第15款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2026-06-25 15:35，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4170-2026-06-25-1534-1jb8ii5","company_id":"4170","company":"鑫品生醫","market":"興櫃","industry":"生技醫療","date":"2026-06-25","time":"15:34:36","subject":"公告本公司115年股東常會重要決議事項","clause":"第15款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：鑫品生醫（4170），2026-06-25 15:34，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4905-2026-06-25-1532-13cil1j","company_id":"4905","company":"台聯電","market":"上櫃","industry":"生技醫療","date":"2026-06-25","time":"15:32:32","subject":"更正本公司115年5月份資金貸與他人明細表資訊","clause":"第53款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：台聯電（4905），2026-06-25 15:32，「更正本公司115年5月份資金貸與他人明細表資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7860-2026-06-25-1516-1m9yg14","company_id":"7860","company":"得生製藥","market":"興櫃","industry":"生技醫療","date":"2026-06-25","time":"15:16:59","subject":"公告本公司審計委員會成員異動","clause":"第6款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：得生製藥（7860），2026-06-25 15:16，「公告本公司審計委員會成員異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7860-2026-06-25-1516-qdi30t","company_id":"7860","company":"得生製藥","market":"興櫃","industry":"生技醫療","date":"2026-06-25","time":"15:16:17","subject":"本公司115年股東常會補選獨立董事當選名單","clause":"第6款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：得生製藥（7860），2026-06-25 15:16，「本公司115年股東常會補選獨立董事當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7860-2026-06-25-1515-1jb8ii5","company_id":"7860","company":"得生製藥","market":"興櫃","industry":"生技醫療","date":"2026-06-25","time":"15:15:35","subject":"公告本公司115年股東常會重要決議事項","clause":"第15款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：得生製藥（7860），2026-06-25 15:15，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6892-2026-06-25-1512-1jb8ii5","company_id":"6892","company":"台寶生醫","market":"興櫃","industry":"生技醫療","date":"2026-06-25","time":"15:12:57","subject":"公告本公司115年股東常會重要決議事項","clause":"第15款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：台寶生醫（6892），2026-06-25 15:12，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4127-2026-06-25-1506-7kag9t","company_id":"4127","company":"天良","market":"上櫃","industry":"生技醫療","date":"2026-06-25","time":"15:06:05","subject":"本公司115年度股東常會流會","clause":"第53款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：天良（4127），2026-06-25 15:06，「本公司115年度股東常會流會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7814-2026-06-25-1505-1lbgq0a","company_id":"7814","company":"海昌生技","market":"上櫃","industry":"生技醫療","date":"2026-06-25","time":"15:05:06","subject":"更新公告本公司股票初次上櫃前現金增資發行新股相關事宜","clause":"第44款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：海昌生技（7814），2026-06-25 15:05，「更新公告本公司股票初次上櫃前現金增資發行新股相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6586-2026-06-25-1440-1jb8ii5","company_id":"6586","company":"醣基","market":"興櫃","industry":"生技醫療","date":"2026-06-25","time":"14:40:52","subject":"公告本公司115年股東常會重要決議事項","clause":"第15款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：醣基（6586），2026-06-25 14:40，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2026-06-25-1344-shx6ge","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2026-06-25","time":"13:44:34","subject":"更正公告本公司法人董事改派代表人(更正事實發生日)","clause":"第6款","fact_date":"2026-06-10","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2026-06-25 13:44，「更正公告本公司法人董事改派代表人(更正事實發生日)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4106-2026-06-25-1119-jflio5","company_id":"4106","company":"雃博","market":"上市","industry":"生技醫療","date":"2026-06-25","time":"11:19:30","subject":"公告本公司115年股東會重要決議事項","clause":"第18款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：雃博（4106），2026-06-25 11:19，「公告本公司115年股東會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8409-2026-06-25-1054-1jb8ii5","company_id":"8409","company":"商之器","market":"上櫃","industry":"生技醫療","date":"2026-06-25","time":"10:54:43","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-06-25","cite_as":"公開資訊觀測站重大訊息：商之器（8409），2026-06-25 10:54，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2026-06-25-0554-1bpj7","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2026-06-25","time":"05:54:12","subject":"代重要子公司Tanvex BioPharma USA, Inc.公告生物相似藥TX05 (Herceptin Biosimilar)產品因下游充填包裝廠查廠問題接獲美國FDA完整回覆信函(CRL)","clause":"第51款","fact_date":"2026-06-24","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2026-06-25 05:54，「代重要子公司Tanvex BioPharma USA, Inc.公告生物相似藥TX05 (Herceptin Biosi」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}